Edition:
United States

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

79.35USD
18 Jan 2018
Change (% chg)

$-0.15 (-0.19%)
Prev Close
$79.50
Open
$79.92
Day's High
$80.69
Day's Low
$79.26
Volume
1,441,208
Avg. Vol
1,924,506
52-wk High
$84.55
52-wk Low
$66.46

Latest Key Developments (Source: Significant Developments)

CVS Health Provides 2018 Outlook
Thursday, 4 Jan 2018 06:55am EST 

Jan 4 (Reuters) - CVS Health Corp ::CVS HEALTH PROVIDES 2018 OUTLOOK.CVS HEALTH CORP - FOR FULL-YEAR 2018, COMPANY EXPECTS TO DELIVER CONSOLIDATED NET REVENUE GROWTH OF 0.75 PCT TO 2.5PCT.CVS HEALTH CORP - EXPECTS NET INTEREST EXPENSE IN A RANGE OF $2.0 BILLION TO $2.3 BILLION IN 2018.CVS HEALTH CORP - ADDITIONALLY, COMPANY REVISED ITS OUTLOOK FOR Q4 OF 2017.CVS HEALTH CORP - EXPECTS ITS EFFECTIVE TAX RATE TO BE ABOUT 27PCT IN 2018.CVS HEALTH CORP - FOR FULL-YEAR 2018, CO EXPECTS ADJUSTED CONSOLIDATED OPERATING PROFIT GROWTH OF 1PCT TO 4PCT.CVS HEALTH CORP - EXPECTS TO MEANINGFULLY BENEFIT IN Q4 FROM TAX CUTS AND JOBS ACT​.CVS HEALTH SAYS WILL BENEFIT FROM RECENT U.S. TAX REFORM SIGNED INTO LAW LAST MONTH.CVS HEALTH CORP - ‍ NOW SEES A MID-TEENS GROWTH RATE IN Q4 2017, ABOUT 4 PERCENT FOR FULL YEAR FOR PHARMACY SERVICES SEGMENT'S ADJUSTED OPERATING PROFIT​.CVS HEALTH- FOR Q4 EXPECTS TO DELIVER ADJUSTED CONSOLIDATED OPERATING PROFIT GROWTH, ADJUSTED EPS AT LOWER END OF RESPECTIVE RANGES PROVIDED DURING Q3 2017.CVS HEALTH CORP - ‍CONTINUES TO EXPECT Q4 OPERATING PROFIT FROM ITS RETAIL/LTC SEGMENT TO BE AT HIGH END OF ITS PREVIOUSLY-PROVIDED RANGE​.CVS HEALTH SAYS CONTINUES TO EXPECT PENDING ACQUISITION OF AETNA TO CLOSE DURING SECOND HALF OF 2018.  Full Article

CVS Health Says On Dec 15, Co Entered Into Term Loan Agreement Providing For Total Term Loan Commitments In Aggregate Principal Amount Of $5.0 Bln
Tuesday, 19 Dec 2017 05:36pm EST 

Dec 19 (Reuters) - CVS Health Corp ::CVS HEALTH - ON DEC 15, CO ENTERED INTO TERM LOAN AGREEMENT PROVIDING FOR TOTAL TERM LOAN COMMITMENTS IN AGGREGATE PRINCIPAL AMOUNT OF $5.0 BILLION.CVS HEALTH SAYS THE TERM LOAN AGREEMENT WAS ENTERED INTO IN CONNECTION WITH PREVIOUSLY ANNOUNCED PROPOSED MERGER OF CO WITH AETNA INC.CVS HEALTH SAYS TERM LOAN FACILITY UNDER TERM LOAN AGREEMENT CONSISTS OF A $3 BILLION 3-YEAR TRANCHE AND A $2 BILLION 5-YEAR TRANCHE - SEC FILING.  Full Article

Moody's says CVS-Aetna merger would have negative implications for other health care companies‍​
Monday, 4 Dec 2017 07:36pm EST 

Dec 4 (Reuters) - :Moody's: CVS-Aetna merger would have negative implications for other health care companies‍​.  Full Article

CVS nears majority cash deal for Aetna - CNBC
Thursday, 30 Nov 2017 09:29am EST 

Nov 30 (Reuters) - :CVS NEARS MAJORITY CASH DEAL FOR AETNA THAT COULD VALUE INSURER AT BETWEEN $200 AND $205 PER SHARE; DEAL COULD BE ANNOUNCED BY MONDAY- CNBC, CITING DJ.  Full Article

CVS Health sets goal of hiring 5,000 new apprentices by 2022​
Tuesday, 14 Nov 2017 08:00am EST 

Nov 14 (Reuters) - CVS Health Corp :CVS Health Corp - ‍has set a goal of hiring 5,000 new apprentices by 2022​.CVS Health Corp - ‍new goal of hiring new apprentices reflects expansion of co's registered apprenticeship program to seven additional states.  Full Article

Mckesson acquires RxCrossroads in a deal valued at $735 mln
Monday, 6 Nov 2017 04:16pm EST 

Nov 6 (Reuters) - Mckesson Corp ::Mckesson strengthens its portfolio of manufacturer solutions with the acquisition of RxCrossroads.Mckesson Corp - ‍transaction is valued at $735 million, or approximately $635 million net of present value of incremental cash tax benefits​.Mckesson Corp - ‍transaction will be funded by cash on hand​.Mckesson - ‍signed agreement to buy RxCrossroads from Cvs Health Corporation​.Mckesson Corp - ‍co expects impact of deal to be about 20 cents accretive to adjusted earnings per diluted share by third year following close of deal​.  Full Article

CVS Health in presentation- Expects FY revenue growth of 3.25-3.75 pct‍​
Monday, 6 Nov 2017 08:33am EST 

Nov 6 (Reuters) - CVS Health Corp :In presentation- expects FY revenue growth of 3.25-3.75 pct‍​.In presentation- expects FY PBM net revenue growth of 8-8.5 percent, adjusted gross margin to modestly decline.In presentation- expects FY retail net revenue to decline 2.25-2.75 percent, adjusted gross margin to modestly improve.In presentation- expects Q4 net revenue to grow 2.5-4.25 percent.In presentation- expects Q4 retail net revenue to decline 0.5-2.25 percent, comp sales to decline 1-2.75 percent.In presentation- expects Q4 pharmacy services revenue to grow 6-7.75 percent.  Full Article

CVS has proposed to acquire Aetna for more than $200 per share - CNBC, citing DJ‍​
Thursday, 26 Oct 2017 04:00pm EDT 

Oct 26 (Reuters) - :CVS has proposed to acquire AETNA for more than $200 per share - CNBC,citing DJ‍​.  Full Article

CVS Health in talks to buy Aetna - CNBC, citing DJ ‍​
Thursday, 26 Oct 2017 03:29pm EDT 

Oct 26 (Reuters) - ‍​:CVS Health in talks to buy Aetna - CNBC, citing DJ ‍​.  Full Article

CVS Health introduces new PBM performance-based pharmacy network
Tuesday, 24 Oct 2017 04:15pm EDT 

Oct 24 (Reuters) - CVS Health Corp :CVS Health introduces new PBM performance-based pharmacy network focused on reducing costs and improving clinical outcomes.Says ‍announced a new 30,000-store performance-based pharmacy network anchored by CVS Pharmacy and Walgreens​.Says ‍CVS Caremark will make this network available to eligible PBM clients for implementation beginning March 2018​.  Full Article

UnitedHealth raises 2018 profit outlook, to take benefit from tax law

UnitedHealth Group Inc on Tuesday raised its outlook for 2018 earnings per share by more than 16 percent due to the U.S. corporate tax cut and said it will speed up technology investments that aim to cut customer costs.